Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check3 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.3 has been added, replacing v3.4.2 in the record history.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.4.2 was added and notices including 'Notice Because of a lapse in government funding...' and 'Revision: v3.4.1' were removed from the history; the rest of the study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check74 days agoChange DetectedAdded a site-wide funding notice banner and the revision tag Revision: v3.4.1; removed the previous Revision: v3.4.0 tag.SummaryDifference0.7%

- Check81 days agoChange DetectedThe page adds a glossary display option and uses green/red highlights to show additions and deletions; there are small textual tweaks such as capitalization of the No FEAR Act data label and the revision tag updated to v3.4.0.SummaryDifference0.8%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.